Atgam

Atgam (Anti-T Lymphocyte Immunoglobulin) is an intravenous medication used to suppress immune responses. It is commonly utilized in transplant patients and autoimmune conditions.

Atgam is primarily used to prevent organ rejection in transplant patients. It works by targeting and reducing the activity of T lymphocytes, which are a type of white blood cell involved in immune responses. This medication may also be used in the treatment of certain autoimmune disorders where immune suppression is beneficial.

Common effects of Atgam may include fever, chills, and allergic reactions. Some patients may experience changes in blood pressure or heart rate during administration. These effects are generally monitored and managed by healthcare professionals.

Atgam should be administered under medical supervision due to its potent immune-suppressing properties. Patients with a history of severe allergic reactions to horse proteins should exercise caution. Regular monitoring of blood counts and immune function is recommended during treatment.

Atgam may interact with other immunosuppressive drugs, increasing the risk of severe immune suppression. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain over-the-counter medications should be used with caution.